AXSOME THERAPEUTICS INC (AXSM) Stock Earnings & Estimates
USA - NASDAQ:AXSM - US05464T1043 - Common Stock
121.04 USD
-1.48 (-1.21%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 50.04M | 270.6M 440.77% | 385.693M 42.53% | 631.08M 63.62% | 982.73M 55.72% | 1.497B 52.33% | 2.046B 36.67% | 2.648B 29.42% | 3.109B 17.41% | 3.23B 3.89% | 3.573B 10.62% | |
| EBITDA YoY % growth | -174.9M -40.34% | -224.991M -28.64% | -272.604M -21.16% | -149.456M 45.17% | 76.446M 151.15% | 452.73M 492.22% | 756.46M 67.09% | 1.126B 48.85% | 1.255B 11.46% | 1.479B 17.85% | N/A | |
| EBIT YoY % growth | -179.3M -43.77% | -231.825M -29.29% | -280.562M -21.02% | -169.069M 39.74% | 54.505M 132.24% | 475.91M 773.15% | 890.69M 87.16% | 1.353B 51.90% | 1.698B 25.50% | 1.608B -5.30% | 1.767B 9.89% | |
| Operating Margin | -358.31% | -85.67% | -72.74% | -26.79% | 5.55% | 31.79% | 43.53% | 51.10% | 54.62% | 49.78% | 49.45% | |
| EPS YoY % growth | -4.57 -31.70% | -5.20 -13.79% | -5.99 -15.19% | -3.75 37.32% | 0.81 121.58% | 8.08 897.89% | 13.22 63.47% | 20.17 52.65% | 26.07 29.24% | 22.08 -15.32% | 23.75 7.57% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.90 33.04% | -0.64 58.32% | -0.55 55.13% | -0.10 89.83% | 0.45 149.76% | 0.95 247.80% | 1.64 400.00% | 1.90 2,024.07% | 2.46 450.50% | 3.14 231.18% |
| Revenue Q2Q % growth | 165.78M 58.24% | 188M 58.29% | 191.95M 58.03% | 222.91M 48.57% | 263.74M 59.09% | 308.94M 64.33% | 251.03M 30.78% | 317.14M 42.27% | 378.22M 43.41% | 479.45M 55.19% |
| EBITDA Q2Q % growth | -38.804M 31.61% | -28.274M 56.27% | -34.619M 39.42% | 326.4K 101.01% | 21.91M 156.46% | 27.407M 196.93% | 92.198M 366.32% | 116.74M 35,665.93% | 139.4M 536.24% | 176.98M 545.75% |
| EBIT Q2Q % growth | -41.924M 33.05% | -29.718M 59.08% | -28.491M 51.94% | -9.404M 74.38% | 14.526M 134.65% | 41.771M 240.56% | 92.198M 423.60% | 116.74M 1,341.33% | 139.4M 859.66% | 176.98M 323.69% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -0.97 41.92% | -1.12 | 0.15 | 13.31% |
| Q1 2025 Q2Q % growth | -1.22 15.28% | -1.35 | 0.13 | 9.80% |
| Q4 2024 Q2Q % growth | -1.54 25.96% | -1.04 | -0.50 | -48.67% |
| Q3 2024 Q2Q % growth | -1.34 -1.52% | -1.44 | 0.10 | 6.83% |
| Q2 2024 Q2Q % growth | -1.67 -8.44% | -1.36 | -0.31 | -22.89% |
| Q1 2024 Q2Q % growth | -1.44 -453.85% | -1.23 | -0.21 | -17.22% |
| Q4 2023 Q2Q % growth | -2.08 -47.52% | -1.19 | -0.89 | -74.11% |
| Q3 2023 Q2Q % growth | -1.32 -23.36% | -1.23 | -0.09 | -7.52% |
| Q2 2023 Q2Q % growth | -1.54 -45.28% | -1.25 | -0.29 | -23.51% |
| Q1 2023 Q2Q % growth | -0.26 74.76% | -1.06 | 0.80 | 75.39% |
| Q4 2022 Q2Q % growth | -1.41 -56.67% | -1.16 | -0.25 | -21.43% |
| Q3 2022 Q2Q % growth | -1.07 -15.05% | -1.10 | 0.03 | 2.80% |
| Q2 2022 Q2Q % growth | -1.06 -23.26% | -1.23 | 0.17 | 13.97% |
| Q1 2022 Q2Q % growth | -1.03 -32.05% | -1.02 | -0.01 | -0.75% |
| Q4 2021 Q2Q % growth | -0.90 -15.38% | -1.04 | 0.14 | 13.63% |
| Q3 2021 Q2Q % growth | -0.93 -60.34% | -0.97 | 0.04 | 4.06% |
| Q2 2021 Q2Q % growth | -0.86 -75.51% | -0.98 | 0.12 | 12.63% |
| Q1 2021 Q2Q % growth | -0.78 11.36% | -0.88 | 0.10 | 11.84% |
| Q4 2020 Q2Q % growth | -0.78 -9.86% | -0.77 | -0.01 | -0.90% |
| Q3 2020 Q2Q % growth | -0.58 -3.57% | -0.58 | 0.00 | 0.62% |
| Q2 2020 Q2Q % growth | -0.49 -19.51% | -0.63 | 0.14 | 22.07% |
| Q1 2020 Q2Q % growth | -0.88 -175.00% | -0.64 | -0.24 | -38.16% |
| Q4 2019 Q2Q % growth | -0.71 | -0.49 | -0.22 | -45.02% |
| Q3 2019 Q2Q % growth | -0.56 | -0.41 | -0.15 | -36.83% |
| Q2 2019 Q2Q % growth | -0.41 | -0.33 | -0.08 | -23.05% |
| Q1 2019 Q2Q % growth | -0.32 | -0.30 | -0.02 | -5.99% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 150.042M 72.13% | 141.54M | 8.502M | 6.01% |
| Q1 2025 Q2Q % growth | 121.463M 61.95% | 122.26M | -797K | -0.65% |
| Q4 2024 Q2Q % growth | 118.766M 66.03% | 120M | -1.234M | -1.03% |
| Q3 2024 Q2Q % growth | 104.762M 81.27% | 100.94M | 3.822M | 3.79% |
| Q2 2024 Q2Q % growth | 87.166M 89.42% | 88.66M | -1.494M | -1.69% |
| Q1 2024 Q2Q % growth | 74.999M -20.70% | 74.761M | 238K | 0.32% |
| Q4 2023 Q2Q % growth | 71.531M 193.52% | 68.915M | 2.616M | 3.80% |
| Q3 2023 Q2Q % growth | 57.794M 242.99% | 55.959M | 1.835M | 3.28% |
| Q2 2023 Q2Q % growth | 46.017M 421.73% | 41.753M | 4.264M | 10.21% |
| Q1 2023 Q2Q % growth | 94.576M | 26.591M | 67.985M | 255.67% |
| Q4 2022 Q2Q % growth | 24.37M | 22.195M | 2.175M | 9.80% |
| Q3 2022 Q2Q % growth | 16.85M | 16.968M | -118K | -0.70% |
| Q2 2022 Q2Q % growth | 8.82M | 6.418M | 2.402M | 37.43% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.06% | -14.6% | -0.17% | -5.2% |
| Revenue | -0.14% | -0.64% | -0.26% | 0.48% |